INNOVENT BIO (01801.HK) is working with a consultant to gauge the interest of global pharmaceutical companies in its self-developed pioneered PD-1/IL-2 Alpha-bias bispecific antibodies fusion ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback